These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21719500)

  • 1. Influence of pre-analytic conditions on the rate of indeterminate T-SPOT.TB tests.
    Zellweger A; Zellweger JP
    Eur Respir J; 2011 Jul; 38(1):221-2. PubMed ID: 21719500
    [No Abstract]   [Full Text] [Related]  

  • 2. Indeterminate test results of T-SPOT.TB performed under routine field conditions.
    Beffa P; Zellweger A; Janssens JP; Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2008 Apr; 31(4):842-6. PubMed ID: 18057053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients.
    Piana F; Codecasa LR; Cavallerio P; Ferrarese M; Migliori GB; Barbarano L; Morra E; Cirillo DM
    Eur Respir J; 2006 Jul; 28(1):31-4. PubMed ID: 16540502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test.
    Lighter J; Rigaud M; Eduardo R; Peng CH; Pollack H
    Pediatrics; 2009 Jan; 123(1):30-7. PubMed ID: 19117857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients.
    Kobashi Y; Mouri K; Obase Y; Fukuda M; Miyashita N; Oka M
    Eur Respir J; 2007 Nov; 30(5):945-50. PubMed ID: 17652312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice.
    Kobashi Y; Sugiu T; Mouri K; Obase Y; Miyashita N; Oka M
    Eur Respir J; 2009 Apr; 33(4):812-5. PubMed ID: 19129287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis.
    Janssens JP; Roux-Lombard P; Perneger T; Metzger M; Vivien R; Rochat T
    Eur Respir J; 2007 Oct; 30(4):722-8. PubMed ID: 17537773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct costs of three models for the screening of latent tuberculosis infection.
    Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2006 Jul; 28(1):45-50. PubMed ID: 16611659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
    Simsek H; Alpar S; Ucar N; Aksu F; Ceyhan I; Gözalan A; Cesur S; Ertek M
    Jpn J Infect Dis; 2010 Mar; 63(2):99-102. PubMed ID: 20332570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for indeterminate result on the QuantiFERON test in an intermediate tuberculosis-burden country.
    Jeong SJ; Han SH; Kim CO; Baek JH; Jin SJ; Ku NS; Choi JY; Song YG; Kim HS; Kim JM
    J Infect; 2011 May; 62(5):347-54. PubMed ID: 21414356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
    Stephan C; Wolf T; Goetsch U; Bellinger O; Nisius G; Oremek G; Rakus Z; Gottschalk R; Stark S; Brodt HR; Staszewski S
    AIDS; 2008 Nov; 22(18):2471-9. PubMed ID: 19005270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.
    Behar SM; Shin DS; Maier A; Coblyn J; Helfgott S; Weinblatt ME
    J Rheumatol; 2009 Mar; 36(3):546-51. PubMed ID: 19228655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in the use of tests to diagnose tuberculosis infection.
    Thompson JE
    N S W Public Health Bull; 2013 Nov; 24(2):92. PubMed ID: 24195852
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis.
    Bienek DR; Chang CK
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1416-21. PubMed ID: 19861016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuantiFERON-TB Gold In-Tube as help for the diagnosis of tuberculosis in a French pediatric hospital.
    Grare M; Derelle J; Dailloux M; Laurain C
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):366-72. PubMed ID: 20071130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
    Diel R; Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a commercial and an in-house T cell-based assay for the diagnosis of Mycobacterium tuberculosis infection.
    Mantegani P; Piana F; Galli L; Scarpellini P; Codecasa L; Lazzarin A; Cirillo D; Fortis C
    New Microbiol; 2007 Jul; 30(3):291-4. PubMed ID: 17802912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis.
    Dewan PK; Grinsdale J; Kawamura LM
    Clin Infect Dis; 2007 Jan; 44(1):69-73. PubMed ID: 17143818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.